425
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Clinical course and disease burden of patients with generalized pustular psoriasis in Portugal: a multicenter retrospective cohort study

ORCID Icon, , , , , , , , , , , , , , , , , , , , , , & show all
Article: 2345728 | Received 14 Mar 2024, Accepted 08 Apr 2024, Published online: 29 Apr 2024

References

  • Rivera-Díaz R, Daudén E, Carrascosa JM, et al. Generalized pustular psoriasis: a review on clinical characteristics, diagnosis, and treatment. Dermatol Ther (Heidelb). 2023;13(3):1–7. doi: 10.1007/s13555-022-00881-0.
  • Armstrong AW, Elston CA, Elewski BE, et al. Generalized pustular psoriasis: a consensus statement from the national psoriasis foundation. J Am Acad Dermatol. 2024;90(4):727–730.
  • Navarini AA, Burden AD, Capon F, et al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol. 2017;31(11):1792–1799. doi: 10.1111/jdv.14386.
  • Puig L, Choon SE, Gottlieb AB, et al. Generalized pustular psoriasis: a global delphi consensus on clinical course, diagnosis, treatment goals and disease management. J Eur Acad Dermatol Venereol. 2023;37(4):737–752. doi: 10.1111/jdv.18851.
  • Choon SE, Lebwohl MG, Turki H, et al. Clinical characteristics and outcomes of generalized pustular psoriasis flares. Dermatology. 2023;239(3):345–354. doi: 10.1159/000529274.
  • Löfvendahl S, Norlin JM, Ericson O, et al. Prolonged sick leave before and after diagnosis of generalized pustular psoriasis: a eneral population-based register study. Acta Derm Venereol. 2023;103:adv6497. doi: 10.2340/actadv.v103.6497.
  • Okubo Y, Kotowsky N, Gao R, et al. Clinical characteristics and health-care resource utilization in patients with generalized pustular psoriasis using real-world evidence from the enerali medical data center database. J Dermatol. 2021;48(11):1675–1687. doi: 10.1111/1346-8138.16084.
  • Patel PM, Sanchez-Melendez SN, Nambudiri VE. A narrative review of studies assessing the quality of life in patients with generalized pustular psoriasis. Exp Dermatol. 2023;32(8):1227–1234. doi: 10.1111/exd.14787.
  • Maçães CO, Lé AM, Torres T. Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors. J Dermatolog Treat. 2022; Oct 333(7):2911–2918. doi: 10.1080/09546634.2022.2089335.
  • Finlay AY, Khan GK. Dermatology life quality index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216. doi: 10.1111/j.1365-2230.1994.tb01167.x.
  • Bellinato F, Gisondi P, Marzano AV, et al. Characteristics of patients experiencing a flare of generalized pustular psoriasis: a multicenter observational study. Vaccines (Basel). 2023;11(4):740. doi: 10.3390/vaccines11040740.
  • Choon SE, Lai NM, Mohammad NA, et al. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: ANALYSIS of 102 cases seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol. 2014;53(6):676–684. doi: 10.1111/ijd.12070.
  • Mastacouris N, Feda A, Strunk A, et al. Risk factors for generalized pustular psoriasis: a case-control study. J Am Acad Dermatol. 2023;89(4):846–848. doi: 10.1016/j.jaad.2023.06.018.
  • Balato A, Ambrogio F, Burlando M, et al. Commentary: unmet needs in generalized pustular psoriasis in clinical practice. Dermatol Ther (Heidelb). 2023;14(1):5–13. doi: 10.1007/s13555-023-01073-0.
  • Choon SE, Navarini AA, Pinter A. Clinical course and characteristics of generalized pustular psoriasis. Am J Clin Dermatol. 2022;23(Suppl 1):21–29. doi: 10.1007/s40257-021-00654-z.
  • Hanna ML, Singer D, Bender SD, et al. Characteristics of hospitalizations and emergency department visits due to generalized pustular psoriasis in the United States. Curr Med Res Opin. 2021;37(10):1697–1703. doi: 10.1080/03007995.2021.1951192.
  • Fujita H, Terui T, Hayama K, et al. Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP. J Dermatol. 2018;45(11):1235–1270. doi: 10.1111/1346-8138.14523.
  • Abduelmula A, Rankin BD, Sood S, et al. Management of adult generalized pustular psoriasis using biologics: a systematic review. J Am Acad Dermatol. 2023;89(2):417–419. doi: 10.1016/j.jaad.2023.04.031.
  • Bernardo D, Thaçi D, Torres T. Spesolimab for the treatment of generalized pustular psoriasis. Drugs [Internet]. 2023;84(1):45–58. doi: 10.1007/s40265-023-01988-0.
  • Capon F. A viewpoint on the genetic determinants of eneralized pustular psoriasis. Exp Dermatol. 2023;32(8):1188–1193. doi: 10.1111/exd.14746.
  • Hawkes JE, Visvanathan S, Krueger JG. The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab. Front Immunol. 2023;14(vember):1292941. doi: 10.3389/fimmu.2023.1292941.